138 related articles for article (PubMed ID: 7774914)
1. A nonsense mutation in the 4-hydroxyphenylpyruvic acid dioxygenase gene (Hpd) causes skipping of the constitutive exon and hypertyrosinemia in mouse strain III.
Endo F; Awata H; Katoh H; Matsuda I
Genomics; 1995 Jan; 25(1):164-9. PubMed ID: 7774914
[TBL] [Abstract][Full Text] [Related]
2. Structure of the human 4-hydroxyphenylpyruvic acid dioxygenase gene (HPD).
Awata H; Endo F; Matsuda I
Genomics; 1994 Oct; 23(3):534-9. PubMed ID: 7851880
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria.
Tomoeda K; Awata H; Matsuura T; Matsuda I; Ploechl E; Milovac T; Boneh A; Scott CR; Danks DM; Endo F
Mol Genet Metab; 2000 Nov; 71(3):506-10. PubMed ID: 11073718
[TBL] [Abstract][Full Text] [Related]
4. A murine model for type III tyrosinemia: lack of immunologically detectable 4-hydroxyphenylpyruvic acid dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia.
Endo F; Katoh H; Yamamoto S; Matsuda I
Am J Hum Genet; 1991 Apr; 48(4):704-9. PubMed ID: 2014797
[TBL] [Abstract][Full Text] [Related]
5. Putative genetic deficiency of 4-hydroxyphenylpyruvic acid dioxygenase in mice: a murine model for hereditary tyrosinaemia type III.
Endo F; Katoh H; Matsuda I
J Inherit Metab Dis; 1990; 13(5):780-2. PubMed ID: 2246865
[No Abstract] [Full Text] [Related]
6. Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III.
Rüetschi U; Cerone R; Pérez-Cerda C; Schiaffino MC; Standing S; Ugarte M; Holme E
Hum Genet; 2000 Jun; 106(6):654-62. PubMed ID: 10942115
[TBL] [Abstract][Full Text] [Related]
7. Primary structure deduced from complementary DNA sequence and expression in cultured cells of mammalian 4-hydroxyphenylpyruvic acid dioxygenase. Evidence that the enzyme is a homodimer of identical subunits homologous to rat liver-specific alloantigen F.
Endo F; Awata H; Tanoue A; Ishiguro M; Eda Y; Titani K; Matsuda I
J Biol Chem; 1992 Dec; 267(34):24235-40. PubMed ID: 1339442
[TBL] [Abstract][Full Text] [Related]
8. In vivo correction with recombinant adenovirus of 4-hydroxyphenylpyruvic acid dioxygenase deficiencies in strain III mice.
Kubo S; Kiwaki K; Awata H; Katoh H; Kanegae Y; Saito I; Yamamoto T; Miyazaki J; Matsuda I; Endo F
Hum Gene Ther; 1997 Jan; 8(1):65-71. PubMed ID: 8989996
[TBL] [Abstract][Full Text] [Related]
9. Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship.
Ploos van Amstel JK; Bergman AJ; van Beurden EA; Roijers JF; Peelen T; van den Berg IE; Poll-The BT; Kvittingen EA; Berger R
Hum Genet; 1996 Jan; 97(1):51-9. PubMed ID: 8557261
[TBL] [Abstract][Full Text] [Related]
10. Tyrosinemia type 1--complex splicing defects and a missense mutation in the fumarylacetoacetase gene.
Rootwelt H; Kristensen T; Berger R; Høie K; Kvittingen EA
Hum Genet; 1994 Sep; 94(3):235-9. PubMed ID: 8076937
[TBL] [Abstract][Full Text] [Related]
11. Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I.
St-Louis M; Leclerc B; Laine J; Salo MK; Holmberg C; Tanguay RM
Hum Mol Genet; 1994 Jan; 3(1):69-72. PubMed ID: 8162054
[TBL] [Abstract][Full Text] [Related]
12. Fungal metabolic model for tyrosinemia type 3: molecular characterization of a gene encoding a 4-hydroxy-phenyl pyruvate dioxygenase from Aspergillus nidulans.
da Silva Ferreira ME; Savoldi M; Sueli Bonato P; Goldman MH; Goldman GH
Eukaryot Cell; 2006 Aug; 5(8):1441-5. PubMed ID: 16896227
[TBL] [Abstract][Full Text] [Related]
13. Complete rescue of lethal albino c14CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway.
Endo F; Kubo S; Awata H; Kiwaki K; Katoh H; Kanegae Y; Saito I; Miyazaki J; Yamamoto T; Jakobs C; Hattori S; Matsuda I
J Biol Chem; 1997 Sep; 272(39):24426-32. PubMed ID: 9305902
[TBL] [Abstract][Full Text] [Related]
14. Animal models reveal pathophysiologies of tyrosinemias.
Endo F; Tanaka Y; Tomoeda K; Tanoue A; Tsujimoto G; Nakamura K
J Nutr; 2003 Jun; 133(6 Suppl 1):2063S-2067S. PubMed ID: 12771366
[TBL] [Abstract][Full Text] [Related]
15. Expression and post-translational modification of human 4-hydroxy-phenylpyruvate dioxygenase.
Aarenstrup L; Falch AM; Jakobsen KK; Neve S; Henriksen L LØ; Tommerup N; Leffers H; Kristiansen K
Cell Biol Int; 2002; 26(7):615-25. PubMed ID: 12127941
[TBL] [Abstract][Full Text] [Related]
16. Four-hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia.
Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
Pediatr Res; 1983 Feb; 17(2):92-6. PubMed ID: 6828337
[TBL] [Abstract][Full Text] [Related]
17. Manifestation of hawkinsinuria in a patient compound heterozygous for hawkinsinuria and tyrosinemia III.
Item CB; Mihalek I; Lichtarge O; Jalan A; Vodopiutz J; Muhl A; Bodamer OA
Mol Genet Metab; 2007 Aug; 91(4):379-83. PubMed ID: 17560158
[TBL] [Abstract][Full Text] [Related]
18. Heterozygosity for an exon 12 splicing mutation and a W234G missense mutation in an American child with chronic tyrosinemia type 1.
Hahn SH; Krasnewich D; Brantly M; Kvittingen EA; Gahl WA
Hum Mutat; 1995; 6(1):66-73. PubMed ID: 7550234
[TBL] [Abstract][Full Text] [Related]
19. Tyrosinemia type III: diagnosis and ten-year follow-up.
Cerone R; Holme E; Schiaffino MC; Caruso U; Maritano L; Romano C
Acta Paediatr; 1997 Sep; 86(9):1013-5. PubMed ID: 9343288
[TBL] [Abstract][Full Text] [Related]
20. A mouse model of renal tubular injury of tyrosinemia type 1: development of de Toni Fanconi syndrome and apoptosis of renal tubular cells in Fah/Hpd double mutant mice.
Sun MS; Hattori S; Kubo S; Awata H; Matsuda I; Endo F
J Am Soc Nephrol; 2000 Feb; 11(2):291-300. PubMed ID: 10665936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
